March 23, 2023

DiMe and Moffitt Cancer Center to Co-Host Cancer Moonshot's New CancerX Public-Private Partnership

March 23, 2023

…GenomateHealth Inc. develops AI-powered computational tools for personalized medicine.Its main focus is assisting physicians in making optimal personalized treatmentdecisions for each patient based on the complex molecular characteristics ofhuman diseases…

Other Media Coverage

See all

Genomate Health Brings European Innovation and $2M in Investment to the United States

May 12, 2025

Read Article

Webinar: DrugBank In Conversation: AI in Precision Oncology, with Genomate

August 30, 2023

Read Article

Fourth Mayo Clinic Platform_Accelerate cohort shows depth, variety of AI healthcare startups

October 18, 2023

Read Article

Other Resources

The Genomate® Report can be used and clinically interpreted only by physicians or other qualified healthcare professionals. Genomate® is a clinical decision support software and is not intended to diagnose, treat, cure, prevent, or mitigate any condition. None of the statements contained herein have been evaluated by the U.S. Food and Drug Administration. Learn more.